Kathy O'Briant

Fred Hutch Cancer CenterUnited States

Medicine · Health Sciences

25h-index10.1kcitations41works0.02yr avg

Accepting Students?

No reports yet. Know if this professor is taking students?


Research Topics

Monoclonal and Polyclonal Antibodies Research(10), Toxin Mechanisms and Immunotoxins(9), Ovarian cancer diagnosis and treatment(8), HER2/EGFR in Cancer Research(7), Cancer-related molecular mechanisms research(5)

Publications41 total

Science Translational Medicine·2013· 59 citedOpen Access
JNCI Journal of the National Cancer Institute·2011· 53 citedOpen Access
Applied immunohistochemistry & molecular morphology·2010· 14 citedOpen Access
JNCI Journal of the National Cancer Institute·2009· 199 citedOpen Access
Proceedings of the National Academy of Sciences·2008· 7.9k citedOpen Access
Clinical Cancer Research·2006· 150 citedOpen Access
Rater agreement and utility of the mutagen-induced chromosome damage assay.
PubMed·2001· 4 cited
Synergistic interaction between anti-p185HER-2 ricin A chain immunotoxins and radionuclide conjugates for inhibiting growth of ovarian and breast cancer cells that overexpress HER-2.
PubMed·2000· 15 cited
International Journal of Cancer·2000· 6 citedOpen Access
page 1 of 3Next →

Frequent Co-authors

Robert C. Bast(13), Charles W. Drescher(12), Nicole Urban(11), Gerold Bepler(11), Muneesh Tewari(6), Beatrice S. Knudsen(5), Martin McIntosh(5), L. Daly(5), Rachael K. Parkin(4), Garnet L. Anderson(4), Jason D. Thorpe(4), Michèl Schummer(4), John T. Soper(4), C. Boyer(4), G Schreiber(4), K DeSombre(4), Andrew K. Godwin(3), Nathalie Scholler(3), Aviva P. Ventura(3), Andrew Berchuck(3)